Stopping Cholesterol Drugs and the Risk of Developing Parkinson’s Disease Author Michael Okun Published On July 20, 2013 Social Media Share this article Facebook Twitter LinkedIn Read about this important topic that broke in the news yesterday online in Neurology. Dr. Okun reviews the paper and give some practical tips on Cholesterol therapy and Parkinson’s disease, and also wrote a free review for the New England Journal of Medicine Journal Watch Neurology. Related posts: Depression a major factor in Parkinson patients’ care Apathy in PD and the related anhedonia and behavioral deficits – Research Report Nilotinib (Tasigna) for Parkinsons: Questions and Answers Non-invasive, automated MRI for Parkinson’s diagnosis About the Author Michael Okun Professor of Neurology, expert on Parkinson's disease and other basal ganglia disorders, deep brain stimulation, author of over 300 research papers and the bestselling book… Read all articles by Michael Okun
